Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards…
What to know about EW
Edwards Lifesciences Corporation is a large Healthcare company with a mixed financial profile. It scores well on growth and health, but valuation is worth keeping an eye on.
Should you consider EW?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
Edwards Lifesciences Corporation is a large-cap Healthcare company with a mixed overall financial profile — it ranks in the top quarter of its Healthcare peers (13 of 59).
-
The business is both profitable and financially healthy — it keeps a good portion of what it earns and carries its debt comfortably.
-
The stock trades at a premium — investors are paying more per dollar of earnings than most S&P 500 companies. That's fine if strong growth justifies it, but leaves little room for disappointment.
-
Growth is a clear strength — revenue and earnings are expanding faster than most peers, signalling strong demand for the company's products or services.
-
This stock pays no dividend — your return depends entirely on the share price rising over time.
-
Volatility is close to the S&P 500 average — typical market swings, nothing unusual.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how EW compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 47.22 | Below avg |
| Forward P/E | 25.94 | Below avg |
| PEG Ratio | 2.13 | Average |
| Price to Sales | 7.98 | Below avg |
| Price to Book | 4.88 | Average |
| EV/EBITDA | 25.23 | Below avg |
| Earnings Yield | 2.12% | Below avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 77.87% | Top 25% |
| Operating Margin | 31.22% | Top 25% |
| Net Profit Margin | 17.39% | Above avg |
| Return on Equity | 10.46% | Average |
| Return on Invested Capital | 8.27% | Above avg |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 16.70% | Top 25% |
| Revenue Growth (3Y CAGR) | 10.77% | Top 25% |
| EPS Growth (YoY) | 8.20% | Average |
| Free Cash Flow Growth | 413.66% | Top 25% |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 4.42 | Top 25% |
| Debt to Equity | 6.81 | Below avg |
| Interest Coverage | 63.40 | Top 25% |
| Altman Z-Score | 11.63 | Top 25% |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | — | N/A |
| Payout Ratio | 0.00% | Top 25% |
| Dividend Growth (5Y) | — | N/A |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 2.17% | Below avg |
| OCF to Sales | 21.55% | Above avg |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.87 | Above avg |
| Volatility (30-Day) | 28.32% | Above avg |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 2.40% | Above avg |
| Avg. Analyst Rating | 1.69 | Above avg |
| Target Upside % | 10.95% | Average |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 50.3B | Above avg |
How does EW compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to EW — based on their financial profile.